Ensysce Biosciences Files 8-K on Operations
Ticker: ENSCW · Form: 8-K · Filed: May 13, 2025 · CIK: 1716947
| Field | Detail |
|---|---|
| Company | Ensysce Biosciences, INC. (ENSCW) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financial-condition, sec-filing
TL;DR
Ensysce Biosciences filed an 8-K, expect an update on financials soon.
AI Summary
Ensysce Biosciences, Inc. filed an 8-K on May 13, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This 8-K filing indicates Ensysce Biosciences is providing updates on its financial condition and operational results to the SEC.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of operational and financial information without immediate material events.
Key Players & Entities
- Ensysce Biosciences, Inc. (company) — Registrant
- Leisure Acquisition Corp. (company) — Former company name
- May 13, 2025 (date) — Date of report
FAQ
What specific financial results are being reported by Ensysce Biosciences?
The provided text of the 8-K filing does not contain specific financial figures or details of the results of operations.
What is the purpose of this 8-K filing?
The purpose of this 8-K filing is to report on the Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
When was this 8-K filed?
This 8-K was filed on May 13, 2025.
What was Ensysce Biosciences' former company name?
Ensysce Biosciences, Inc. was formerly known as Leisure Acquisition Corp.
Where is Ensysce Biosciences, Inc. headquartered?
Ensysce Biosciences, Inc. is headquartered at 7946 Ivanhoe Avenue, Suite 201, La Jolla, California, 92037.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Ensysce Biosciences, Inc. (ENSCW).